These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32197726)

  • 1. Cost-Effectiveness Analysis of Screening for Persistent Hepatitis E Virus Infection in Solid Organ Transplant Patients in the United Kingdom: A Model-Based Economic Evaluation.
    Ankcorn MJ; Tedder RS; Cairns J; Sandmann FG
    Value Health; 2020 Mar; 23(3):309-318. PubMed ID: 32197726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Systematic Screening for Persistent Hepatitis E Virus Infections in Transplant Patients.
    Ankcorn MJ; Ijaz S; Poh J; Elsharkawy AM; Smit E; Cramb R; Ravi S; Martin K; Tedder R; Neuberger J
    Transplantation; 2018 Jul; 102(7):1139-1147. PubMed ID: 29953421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Markov Analysis of Screening for Late-Onset Cytomegalovirus Disease in Cytomegalovirus High-Risk Kidney Transplant Recipients.
    Puttarajappa CM; Hariharan S; Smith KJ
    Clin J Am Soc Nephrol; 2018 Feb; 13(2):290-298. PubMed ID: 29025787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.
    McKay AJ; Hogan H; Humphries SE; Marks D; Ray KK; Miners A
    Atherosclerosis; 2018 Aug; 275():434-443. PubMed ID: 29937236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.
    Nherera L; Marks D; Minhas R; Thorogood M; Humphries SE
    Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis E Virus Infection in Blood Donors and Risk to Patients in the United States and Canada.
    Delage G; Fearon M; Gregoire Y; Hogema BM; Custer B; Scalia V; Hawes G; Bernier F; Nguyen ML; Stramer SL
    Transfus Med Rev; 2019 Jul; 33(3):139-145. PubMed ID: 31324552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
    Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
    J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.
    Ying T; Tran A; Webster AC; Klarenbach SW; Gill J; Chadban S; Morton R
    Am J Kidney Dis; 2020 May; 75(5):693-704. PubMed ID: 31810731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
    Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
    Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis.
    Hansrivijit P; Trongtorsak A; Puthenpura MM; Boonpheng B; Thongprayoon C; Wijarnpreecha K; Choudhury A; Kaewput W; Mao SA; Mao MA; Jadlowiec CC; Cheungpasitporn W
    World J Gastroenterol; 2021 Mar; 27(12):1240-1254. PubMed ID: 33828397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-Effectiveness of One-Time Birth Cohort Screening for Hepatitis C as Part of the National Health Service Health Check Program in England.
    Williams J; Miners A; Harris R; Mandal S; Simmons R; Ireland G; Hickman M; Gore C; Vickerman P
    Value Health; 2019 Nov; 22(11):1248-1256. PubMed ID: 31708061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.
    Smith AF; Hall PS; Hulme CT; Dunn JA; McConkey CC; Rahman JK; McCabe C; Mehanna H
    Eur J Cancer; 2017 Nov; 85():6-14. PubMed ID: 28881249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis E infection in stem cell and solid organ transplantpatients: A cross-sectional study: The importance of HEV RNA screening in peri-transplant period.
    Reekie I; Irish D; Ijaz S; Fox T; Bharucha T; Griffiths P; Thorburn D; Harber M; MacKinnon S; Sekhar M
    J Clin Virol; 2018 Oct; 107():1-5. PubMed ID: 30099145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted hepatitis E vaccination for women of childbearing age is cost-effective in China.
    Xia R; Sun S; Shen M; Zhang L; Zhuang G
    Vaccine; 2019 Sep; 37(39):5868-5876. PubMed ID: 31443991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost-effectiveness of screening for oral cancer in primary care.
    Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
    Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of screening strategies to detect heart failure in patients with type 2 diabetes.
    van Giessen A; Boonman-de Winter LJ; Rutten FH; Cramer MJ; Landman MJ; Liem AH; Hoes AW; Koffijberg H
    Cardiovasc Diabetol; 2016 Mar; 15():48. PubMed ID: 27001409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.
    Robotham JV; Deeny SR; Fuller C; Hopkins S; Cookson B; Stone S
    Lancet Infect Dis; 2016 Mar; 16(3):348-56. PubMed ID: 26616206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of screening immigrants for hepatitis B.
    Wong WW; Woo G; Jenny Heathcote E; Krahn M
    Liver Int; 2011 Sep; 31(8):1179-90. PubMed ID: 21745300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.